| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.31 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |